Stay updated on Dostarlimab Combo in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Dostarlimab Combo in Endometrial Cancer Clinical Trial page.

Latest updates to the Dostarlimab Combo in Endometrial Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 on the page.SummaryDifference0.0%

- Check27 days agoChange DetectedAdded a glossary display option; updated metadata to include Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, while removing the previous QC term Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.1%

- Check34 days agoChange DetectedThe Study Record Dates section now displays a concrete 'Last Update Posted' timestamp, replacing the previous 'Last Update Posted (Estimated)' label. This clarifies the timing of the update without altering the underlying study data.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page now shows Revision: v3.3.4, replacing the previous Revision: v3.3.3.SummaryDifference0.0%

- Check62 days agoChange DetectedAdded Locations sections listing participating sites across many US states and Canadian provinces. Revision updated from v3.3.2 to v3.3.3.SummaryDifference1%

Stay in the know with updates to Dostarlimab Combo in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dostarlimab Combo in Endometrial Cancer Clinical Trial page.